Anaphylaxis to Pepto-Bismol.
More
D
D
2200 Bergquist Drive, Suite 1/MMIA, Lackland AFB, TX 78236, USA. Daniel.More@Lackland.af.mil
Whisman
B
B
Johns
J
J
Hagan
L
L
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000276:immunology; D001729:Bismuth / Q000009:adverse effects* / Q000276:immunology; D004342:Drug Hypersensitivity / Q000209:etiology; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000187:drug effects / Q000276:immunology; D008297:Male; D009942:Organometallic Compounds / Q000009:adverse effects* / Q000276:immunology; D015203:Reproducibility of Results; D012459:Salicylates / Q000009:adverse effects* / Q000276:immunology; D012882:Skin Tests; D014481:United States / Q000453:epidemiology; D014581:Urticaria / Q000139:chemically induced / Q000175:diagnosis / Q000276:immunology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009942:Organometallic Compounds; D012459:Salicylates; D007073:Immunoglobulin E; C015715:bismuth subsalicylate; D001729:Bismuth